4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with omeprazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kitazawa, S; Kyoi, T; Tajima, K; Ukai, Y; Zhang, X | 1 |
1 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and omeprazole
Article | Year |
---|---|
Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Anti-Ulcer Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Gastric Mucosa; Male; Omeprazole; Peroxidase; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rolipram; Stomach Ulcer; Triazines; Tumor Necrosis Factor-alpha | 2004 |